
|Articles|August 15, 2003
Dry-eye treatment drops under review by FDA
Durham, NC-Inspire Pharmaceuticals Inc. is asking the FDA for approval to market diquafosol tetrasodium (INS365) eye drops in a 2% preservative-free solution for the treatment of dry eye.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Reasoning prompts sharpen multimodal AI on bilingual ophthalmology exam questions
3
TECNIS PureSee IOL launches in US following FDA approval for cataract surgery
4
Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
5





















